← Back to Knowledge Base

Primary topic: MMACHC gene B12 transport and cellular use

MMACHC Gene and Metabolism: What It Can Mean in a Pathway Report

MMACHC is tracked because it connects to B12 delivery, intracellular cobalamin processing, and methylation support. The current evidence index links this gene to B12 transport with 4 SNPs and 4 curated claims.

What is the MMACHC gene?

Intracellular cobalamin processing needed to generate active methylcobalamin and adenosylcobalamin cofactors.

How MMACHC affects metabolism

When MMACHC-related function is shifted, the practical effect is interpreted through B12 delivery, intracellular cobalamin processing, and methylation support. This does not mean the pathway is active or impaired right now; it means the gene can help prioritize what to check next.

What happens when MMACHC is altered

Altered MMACHC signal should be treated as a DNA-based tendency, not a diagnosis. 4 claims currently pass the report-use gate. The useful question is whether symptoms, labs, and lifestyle context line up with the pathway signal.

Curated SNP evidence for MMACHC

These SNPs come from the approved study-level evidence model. Each claim is scored from curated study rows, then gated before it can influence pathway scoring.

Evidence-backed report connection

MMACHC currently has 4 curated SNPs, 4 claim-level scores, and 4 claims eligible for pathway scoring.

Open the sample report
rs121918241MMACHC p.Arg132Ter1 claims · 2 study rows

biomarker tendency · TT or compound-heterozygous MMACHC deficiency context

Intracellular cobalamin processing tendency

Strong

rs121918241 T / MMACHC p.Arg132Ter is associated with lower intracellular cobalamin processing tendency in recessive or compound-heterozygous cblC contexts.

MMACHC rs121918241 T is staged as a recessive cblC loss-of-function allele affecting intracellular B12 processing and methylmalonate/homocysteine biology.

Likely effectLower biomarker tendency
Signal sizeModerate signal
Evidence supportStrong support
Report useIncluded in pathway scoring
Show study evidence
rs121918242MMACHC p.Arg111Ter1 claims · 2 study rows

biomarker tendency · TT or compound-heterozygous MMACHC deficiency context

Intracellular cobalamin processing tendency

Strong

rs121918242 T / MMACHC c.331C>T / p.Arg111Ter is associated with lower intracellular cobalamin processing tendency in recessive or compound-heterozygous cblC contexts.

MMACHC rs121918242 T is staged as a recessive cblC loss-of-function allele affecting intracellular B12 processing and methylmalonate/homocysteine biology.

Likely effectLower biomarker tendency
Signal sizeModerate signal
Evidence supportStrong support
Report useIncluded in pathway scoring
Show study evidence
rs121918243MMACHC p.Arg161Gln1 claims · 2 study rows

biomarker tendency · AA or compound-heterozygous MMACHC deficiency context

Intracellular cobalamin processing tendency

Strong

rs121918243 A / MMACHC p.Arg161Gln is associated with lower intracellular cobalamin processing tendency in recessive or compound-heterozygous cblC contexts.

MMACHC rs121918243 A is staged as a recessive cblC allele affecting intracellular B12 processing and methylmalonate/homocysteine biology.

Likely effectLower biomarker tendency
Signal sizeModerate signal
Evidence supportStrong support
Report useIncluded in pathway scoring
Show study evidence
rs398124292MMACHC c.271dupA / Arg91fs1 claims · 2 study rows

biomarker tendency · dupA/dupA or compound-heterozygous MMACHC deficiency context

Intracellular cobalamin processing tendency

Strong

rs398124292 dupA / MMACHC c.271dupA p.Arg91fs is associated with lower intracellular cobalamin processing tendency in recessive or compound-heterozygous cblC contexts.

MMACHC rs398124292 dupA is staged as a recurrent cblC frameshift allele affecting intracellular B12 processing and methylmalonate/homocysteine biology.

Likely effectLower biomarker tendency
Signal sizeModerate signal
Evidence supportStrong support
Report useIncluded in pathway scoring
Show study evidence

Common symptoms people report

  • fatigue or brain fog despite B12 intake
  • nerve or red-blood-cell context needing follow-up
  • unclear B12, MMA, or homocysteine patterns

Biomarkers to validate

Serum B12 and methylmalonic acid

Helps distinguish B12 amount from functional use.

Homocysteine

Adds methylation and B12-use context.

CBC and MCV

Checks whether red-blood-cell markers support the pattern.

Where DNA analysis helps

DNA helps decide whether MMACHC deserves attention inside the broader B12 transport pathway. It is most useful when combined with biomarkers instead of used as a standalone answer.

Example interpretation

MMACHC may add context to B12 delivery, intracellular cobalamin processing, and methylation support, especially when its SNP evidence lines up with other genes in the same pathway.

Suggested validation: Serum B12 and methylmalonic acid.

What to do next

  • Review the B12 transport pathway result before interpreting MMACHC on its own.
  • Use relevant biomarkers to confirm whether this DNA tendency is visible in current biology.
  • Treat supplement or nutrition decisions as follow-up steps only after the pattern fits symptoms or labs.

Upload your DNA file and receive a structured metabolic pathway analysis with prioritized insights and suggested validation markers.

Get My DNA Report

Related pages